TSCQ study: a randomized, controlled, open-label trial of daily trimethoprim-sulfamethoxazole or weekly chloroquine among adults on antiretroviral therapy in Malawi: study protocol for a randomized controlled trial

BACKGROUND: Before antiretroviral therapy (ART) became widely available in sub-Saharan Africa, several studies demonstrated that daily trimethoprim-sulfamethoxazole (TS) prophylaxis reduced morbidity and mortality among HIV-infected adults. As a result, the World Health Organization (WHO) recommende...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Trials
Hoofdauteurs: Laurens, Matthew B., Mungwira, Randy G., Nyirenda, Osward M., Divala, Titus H., Kanjala, Maxwell, Muwalo, Francis, Mkandawire, Felix A., Tsirizani, Lufina, Nyangulu, Wongani, Mwinjiwa, Edson, Taylor, Terrie E., Mallewa, Jane, Blackwelder, William C., Plowe, Christopher V., Laufer, Miriam K., van Oosterhout, Joep J.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: BioMed Central 2016
Onderwerpen:
Study Protocol
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4950772/
https://ncbi.nlm.nih.gov/pubmed/27431995
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-016-1392-3
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items